Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

Sterling Edmonds; Andrea Macgregor; Agnieszka Doll; Ipek Eren Vural; Janice Graham; Katherine Fierlbeck; Joel Lexchin; Peter Doshi; Matthew Herder

doi:10.1093/jlb/lsaa083

Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

Sterling Edmonds, Andrea Macgregor, Agnieszka Doll, Ipek Eren Vural, Janice Graham, Katherine Fierlbeck, Joel Lexchin, Peter Doshi, Matthew Herder

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Original language	English
Article number	lsaa083
Journal	Journal of Law and the Biosciences
Volume	7
Issue number	1
DOIs	https://doi.org/10.1093/jlb/lsaa083
Publication status	Published - Jan 1 2020

ASJC Scopus Subject Areas

Law
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Medicine (miscellaneous)

Keywords

COVID-19
pandemic
pharmaceutical regulation
transparency
vaccines and drugs

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jlb/lsaa083

Cite this

Edmonds, S., Macgregor, A., Doll, A., Vural, I. E., Graham, J., Fierlbeck, K., Lexchin, J., Doshi, P., & Herder, M. (2020). Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19. Journal of Law and the Biosciences, 7(1), Article lsaa083. https://doi.org/10.1093/jlb/lsaa083

@article{d170d53116ce46338bb277bea2c14bb1,

title = "Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19",

keywords = "COVID-19, pandemic, pharmaceutical regulation, transparency, vaccines and drugs",

author = "Sterling Edmonds and Andrea Macgregor and Agnieszka Doll and Vural, {Ipek Eren} and Janice Graham and Katherine Fierlbeck and Joel Lexchin and Peter Doshi and Matthew Herder",

year = "2020",

month = jan,

day = "1",

doi = "10.1093/jlb/lsaa083",

language = "English",

volume = "7",

journal = "Journal of Law and the Biosciences",

issn = "2053-9711",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

AU - Edmonds, Sterling

AU - Macgregor, Andrea

AU - Doll, Agnieszka

AU - Vural, Ipek Eren

AU - Graham, Janice

AU - Fierlbeck, Katherine

AU - Lexchin, Joel

AU - Doshi, Peter

AU - Herder, Matthew

PY - 2020/1/1

Y1 - 2020/1/1

KW - COVID-19

KW - pandemic

KW - pharmaceutical regulation

KW - transparency

KW - vaccines and drugs

UR - http://www.scopus.com/inward/record.url?scp=85098010283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098010283&partnerID=8YFLogxK

U2 - 10.1093/jlb/lsaa083

DO - 10.1093/jlb/lsaa083

M3 - Article

AN - SCOPUS:85098010283

SN - 2053-9711

VL - 7

JO - Journal of Law and the Biosciences

JF - Journal of Law and the Biosciences

IS - 1

M1 - lsaa083

ER -

Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Cite this